hydroxychloroquine
Showing 1 - 25 of 235
Individuals Undergoing Cardiac and General Surgery Trial in Durham (Hydroxychloroquine)
Recruiting
- Individuals Undergoing Cardiac and General Surgery
- Hydroxychloroquine
-
Durham, North CarolinaDuke Health
Dec 1, 2022
Graves Ophthalmopathy Trial in Taipei (Hydroxychloroquine)
Recruiting
- Graves Ophthalmopathy
- Hydroxychloroquine
-
Hsinchu, Taiwan
- +1 more
Dec 1, 2022
Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis
Recruiting
- Nonalcoholic Steatohepatitis
- hydroxychloroquine
-
Taipei, Taiwan
- +1 more
Feb 8, 2023
Interstitial Lung Disease, Surfactant Dysfunction Trial in Shanghai (Hydroxychloroquine)
Not yet recruiting
- Interstitial Lung Disease
- Surfactant Dysfunction
- Hydroxychloroquine
-
Shanghai, Shanghai, ChinaChildren's hospital of Fudan University
Jan 9, 2023
Pericarditis Idiopathic Recurrent Trial in Athens (Hydroxychloroquine, Colchicine)
Not yet recruiting
- Pericarditis Idiopathic Recurrent
- Hydroxychloroquine
- Colchicine
-
Athens, Attiki, Greece"Hippokration" General Hospital of Athens
Feb 20, 2023
Diabetes Type 2 With Hyperglycemia Trial in Los Angeles (Hydroxychloroquine, Pioglitazone)
Terminated
- Diabetes Mellitus Type 2 With Hyperglycemia
- Hydroxychloroquine
- Pioglitazone
-
Los Angeles, CaliforniaCharles Drew University of Medicine and Science
Sep 23, 2022
Metastatic Colorectal Cancer Trial in Toronto (Hydroxychloroquine, Irinotecan, Leucovorin)
Not yet recruiting
- Metastatic Colorectal Cancer
- Hydroxychloroquine
- +4 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 24, 2023
Prostate Cancer Trial in Darlinghurst (SUBA-itraconazole, Hydroxychloroquine)
Recruiting
- Prostate Cancer
- SUBA-itraconazole
- Hydroxychloroquine
-
Darlinghurst, New South Wales, AustraliaSt Vincent's Hospital
May 3, 2022
Breast Cancer, Gynecologic Cancer, Early-stage Breast Cancer Trial in Tucson (Hydroxychloroquine)
Not yet recruiting
- Breast Cancer
- +4 more
- Hydroxychloroquine
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Jan 9, 2023
Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Salt Lake City
Recruiting
- Metastatic Pancreatic Carcinoma
- +6 more
- Hydroxychloroquine
- Trametinib
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Oct 31, 2022
Preeclampsia Trial (Hydroxychloroquine)
Not yet recruiting
- Preeclampsia
- Hydroxychloroquine
- (no location specified)
Mar 10, 2022
Arthritis, Arthralgia Trial in Edmonton (Hydroxychloroquine, Placebo)
Recruiting
- Arthritis
- Arthralgia
- Hydroxychloroquine
- Placebo
-
Edmonton, Alberta, CanadaCross Cancer Institute
Jan 17, 2023
COVID-19 Infection Trial in Strasbourg (Hydroxychloroquine, Azithromycin, Telmisartan)
Terminated
- COVID-19 Infection
- Hydroxychloroquine
- +2 more
-
Strasbourg, FranceCHU de Strasbourg
Jul 7, 2022
Gastrointestinal Tumors Trial in Salt Lake City (Ulixertinib, Hydroxychloroquine)
Recruiting
- Gastrointestinal Neoplasms
- Ulixertinib
- Hydroxychloroquine
-
Salt Lake City, UtahHuntsman Cancer Institute
Mar 1, 2022
COVID-19, Severe Acute Respiratory Syndrome Trial in Mexico, City (Hydroxychloroquine, Placebo oral tablet)
Completed
- COVID-19
- Severe Acute Respiratory Syndrome
- Hydroxychloroquine
- Placebo oral tablet
-
Mexico, City, MexicoInstituto Nacional de Enfermedades Respiratorias, "Ismael Cosío
Jan 17, 2022
Gastrointestinal Cancer Trial in New York, Providence (Cobimetinib, Hydroxychloroquine, Atezolizumab)
Active, not recruiting
- Gastrointestinal Cancer
- Cobimetinib
- +2 more
-
New York, New York
- +1 more
Nov 29, 2022
Recurrent Pregnancy Loss Trial (Hydroxychloroquine)
Not yet recruiting
- Recurrent Pregnancy Loss
- Hydroxychloroquine
- (no location specified)
Feb 9, 2022
Multiple Myeloma Trial in Oslo, Trondheim (Hydroxychloroquine, Carfilzomib Injection, Dexamethasone)
Completed
- Multiple Myeloma
- Hydroxychloroquine
- +2 more
-
Oslo, Norway
- +1 more
Mar 16, 2022
Breast Cancer Stage IIB Trial in Philadelphia (Hydroxychloroquine, Everolimus)
Recruiting
- Breast Cancer Stage IIB
- Hydroxychloroquine
- Everolimus
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jun 8, 2022
SARS-CoV Infection, Covid19 Trial in New Brunswick (Nitazoxanide, Placebo Nitazoxanide, Ribavirin)
Terminated
- SARS-CoV Infection
- Covid19
- Nitazoxanide
- +5 more
-
New Brunswick, New JerseyRobert Wood Johnson Medical School
May 3, 2022
Coronavirus Infection, Coronavirus, Infectious Disease Trial in Salt Lake City (Hydroxychloroquine, Placebo oral tablet)
Active, not recruiting
- Coronavirus Infection
- +2 more
- Hydroxychloroquine
- Placebo oral tablet
-
Salt Lake City, UtahUniversity of Utah
Nov 1, 2022
COVID-19, SARS-CoV 2 Trial in Sioux Falls (Hydroxychloroquine, Vitamin D)
Terminated
- COVID-19
- SARS-CoV 2
- Hydroxychloroquine
- Vitamin D
-
Sioux Falls, South DakotaSanford Health
Dec 8, 2021
COVID-19, Severe Acute Respiratory Syndrome Trial in Mexico, City (Hydroxychloroquine, Placebo oral tablet)
Completed
- COVID-19
- Severe Acute Respiratory Syndrome
- Hydroxychloroquine
- Placebo oral tablet
-
Mexico, City, MexicoInstituto Nacional de Enfermedades Respiratorias, "Ismael Cosío
Jan 17, 2022